Volume : XI, Issue : VII, July - 2021

A RANDOMIZED CONTROLLED TRIAL OF LOW DOSE ANTI-THYMOCYTE GLOBULIN PLUS RITUXIMAB VERSUS CONVENTIONAL DOSE OF ANTI -THYMOCYTE GLOBULIN ALONE AS INDUCTION AGENT IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS.

Dr. Srilatha Vadlamudi, Dr. Sireesha Gunnam, Dr. Moturu Venkata Viswanath

Abstract :

Keywords :

Article: Download PDF    DOI : 10.36106/ijar  

Cite This Article:

A RANDOMIZED CONTROLLED TRIAL OF LOW DOSE ANTI-THYMOCYTE GLOBULIN PLUS RITUXIMAB VERSUS CONVENTIONAL DOSE OF ANTI -THYMOCYTE GLOBULIN ALONE AS INDUCTION AGENT IN HIGH-RISK RENAL TRANSPLANT RECIPIENTS., Dr. Srilatha Vadlamudi, Dr. Sireesha Gunnam, Dr. Moturu Venkata Viswanath INDIAN JOURNAL OF APPLIED RESEARCH : Volume-11 | Issue-7 | July-2021

Number of Downloads : 121

References :